BioCentury | Nov 6, 2017
Distillery Therapeutics

Cardiovascular

...a mouse model of pressure overload-induced heart failure, subcutaneous injection of the GHRH receptor agonist BIS-5409...
...testing GHRH receptor agonists in additional models of heart failure. Biscayne Pharmaceuticals Inc. has BIS-5409 (MR-409...
...Center, Miami, Fla. email: andrew.schally@va.gov CONTACT: Riccarda Granata, University of Turin, Turin, Italy email: riccarda.granata@unito.it Hongjiang Li BIS-5409 Growth...
BioCentury | Nov 19, 2015
Distillery Therapeutics

Therapeutics: Growth hormone-releasing hormone (GHRH) receptor

...transplant to treat diabetes. In a rat pancreatic β cell line, the GHRH receptor agonist MR-409...
...mice receiving rat islet transplants, pretreatment of islets with MR-409 and post-transplant subcutaneous administration of MR-409...
...with the agonist. Next steps by Biscayne Pharmaceuticals Inc. include IND-enabling studies. Biscayne Pharmaceuticals has MR-409...
BioCentury | Sep 8, 2014
Emerging Company Profile

Biscayne: Antagonizing cancer

...that have publicly disclosed peptide antagonist programs targeting GHRH. Biscayne also has a GHRH agonist, BIS-5409...
Items per page:
1 - 3 of 3